BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11966831)

  • 1. Incidence and tumour stages of breast cancer in the region of Aachen, Germany.
    Seemayer CA; Breuer E; Kroll G; Markus-Sellhaus S; Reineke TH; Mittermayer C
    Eur J Cancer Care (Engl); 2002 Mar; 11(1):16-24. PubMed ID: 11966831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening.
    Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW
    Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme.
    Schouten LJ; de Rijke JM; Huveneers JA; Verbeek AL
    J Med Screen; 2002; 9(3):120-4. PubMed ID: 12370323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation of breast cancer tumour stage and the degree of registration in a population-based cancer registry].
    Katalinic A; Holzmann M; Kunze U
    Gesundheitswesen; 2003; 65(8-9):509-15. PubMed ID: 14505270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
    Taylor R; Boyages J
    J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany.
    Schott G; Reichel M; Junkermann H; Becker N
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):29-35. PubMed ID: 17602243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in therapy for breast cancer patients as a result of mammography screening. An analysis of Bavarian cancer registry data from 2000 to 2008].
    Schrodi S; Braisch U; Schenkirsch G; Maisel T; Petsch S; Hölzel D; Klinkhammer-Schalke M; Mäder U; Schuller L; Heywang-Köbrunner SH; Meyer M; Engel J
    Gesundheitswesen; 2013 Oct; 75(10):632-42. PubMed ID: 23404360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
    Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
    Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
    Lousdal ML; Kristiansen IS; Møller B; Støvring H
    Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval cancers in the Dutch breast cancer screening programme.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
    Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, The Netherlands.
    Schouten LJ; de Rijke JM; Schlangen JT; Verbeek AL
    J Med Screen; 1998; 5(1):37-41. PubMed ID: 9575459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
    van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer in southeast North Brabant and in North Limburg; trends in incidence and earlier diagnosis in an unscreened female population, 1975-1986].
    Coebergh JW; Crommelin MA; Kluck HM; van Beek M; van der Horst F; Verhagen-Teulings MT
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):760-5. PubMed ID: 2336113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes.
    Taylor R; Supramaniam R; Rickard M; Estoesta J; Moreira C
    J Med Screen; 2002; 9(1):20-5. PubMed ID: 11943793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the Czech National Breast Cancer screening programme].
    Skovajsová M; Májek O; Daneš J; Bartoňková H; Ngo O; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():69-78. PubMed ID: 25494891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme.
    Peeters PH; Verbeek AL; Straatman H; Holland R; Hendriks JH; Mravunac M; Rothengatter C; Van Dijk-Milatz A; Werre JM
    Int J Epidemiol; 1989 Jun; 18(2):295-9. PubMed ID: 2788627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.